Agios Pharmaceuticals, Inc.
Cambridge, MA
- UEI
- KKWAB4MN58M3
- CAGE
- 86WZ9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 88 Sidney St, Cambridge, MA 02139, USA
- Website
- agios.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $73,080 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $73,080 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pharmaceutical aqvesme - 3 month supply. | Veterans Integrated Service Network 20 (VHA) | $73,080 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Botanix SB Inc. | Phoenix, AZ | 325412 Pharmaceutical Preparation Manufacturing |
| Argenx US, Inc. | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Arrowhead Pharmaceuticals, Inc. | Pasadena, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Lantheus Medical Imaging, Inc. | Bedford, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Agios Pharmaceuticals, Inc. (doing business as Agios), based in Cambridge, Massachusetts, operates as a pharmaceutical supplier and manufacturer serving the Department of Veterans Affairs as a prime contractor through GSA Schedule and blanket purchase agreements, with no set-aside designations across its federal footprint.
Agios holds a position on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and supplies two branded pharmaceutical products — AQVESME and PYRUKYND — to VA health system networks. The company's federal portfolio consists entirely of GSA Schedule activity and derivative blanket purchase agreements. The single-award BPA established by the National Acquisition Center on August 6, 2026, carries a $4 million ceiling through August 5, 2027, and covers both products. Under that BPA, Veterans Integrated Service Network 20 issued a delivery order on July 15, 2026, for a three-month AQVESME supply valued at $73,080.48, with performance at Cary, North Carolina and completion by October 15, 2026. A separate VA Federal Supply Schedule contract awarded September 29, 2025, carries a $225,000 ceiling through September 28, 2030, and reflects a permanent lifecycle change for one National Drug Code in the drugs, pharmaceuticals, and hematology related products category.
Customer concentration is entirely within the Department of Veterans Affairs: the National Acquisition Center holds the highest potential value ($4 million combined potential value), while Veterans Integrated Service Network 12 and Veterans Integrated Service Network 20 together represent $523 thousand in combined potential value across two awards. The Pharmaceuticals and Drugs schedule accounts for all task order activity, with $4.1 million in combined potential value across two task orders. The vendor's recent award trajectory shows minimal volume — one award in 2019, one in 2025, and two in 2026 — with obligated spending of only $73 thousand against $4.5 million in combined potential value, indicating early deployment or prepositioning on VA pharmaceutical supply relationships rather than sustained high-volume ordering.
Quick answers
Is Agios Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Agios Pharmaceuticals, Inc.'s SAM.gov registration is active through February 23, 2027.
What is Agios Pharmaceuticals, Inc.'s CAGE code?
Agios Pharmaceuticals, Inc.'s CAGE code is 86WZ9, and its Unique Entity ID (UEI) is KKWAB4MN58M3.
Which contract vehicles does Agios Pharmaceuticals, Inc. hold?
Agios Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Agios Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $73,080 to Agios Pharmaceuticals, Inc. in fiscal years 2023 through 2027.
What is Agios Pharmaceuticals, Inc.'s most recent federal award?
Agios Pharmaceuticals, Inc.'s most recent federal contract award is Pharmaceutical aqvesme - 3 month supply (36C26026F0349), from Veterans Integrated Service Network 20 (VHA), on July 15, 2026.
On GovTribe
See Agios Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors